Back to Basics
The only assets that GAP hold are the drug patents. They do not generate revenue. We will only know the true value of the patents when the company is bought out. The timing of this is anyones guess. In the meantime, the day-to-day SP is essentially arbitrary , and we (longs) should not get too hung up on it. Either we have faith in the drug, or we don't: and we either trust IIROC or we don't.
I do: and I do.